<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - ACUR</title>
<description>International Business News - ACUR</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Russell 2000 adds 53 health care companies</title>
  <description>More than 50 companies in the health care sector were added to the Russell 2000 in this year&amp;#39;s reconstitution of the small stock index, while 30 companies in the sector were removed from the index.</description>
    <link>http://www.ibtimes.com/articles/20080630/russell-2000-adds-53-health-care-companies.htm</link> 
  <pubDate>Mon, 30 Jun 2008 14:16:09 EDT</pubDate>
  </item>


  <item>
  <title>Acura Pharma gets $5 million fee from King Pharma</title>
  <description>Acura Pharmaceuticals Inc. said Monday it received a $5 million milestone payment from King Pharmaceuticals Inc. for meeting the main goals of a late-stage study on pain relief drug Acurox.</description>
    <link>http://www.ibtimes.com/articles/20080630/acura-pharma-gets-5-million-fee-from-king-pharma.htm</link> 
  <pubDate>Mon, 30 Jun 2008 13:55:02 EDT</pubDate>
  </item>


  <item>
  <title>Acura pain pill meets goal in late-stage trial</title>
  <description>Acura Pharmaceuticals Inc. said Tuesday that it late-stage trial of its pain pill Acurox met its goal. The drug contains the prescription pain drug oxycodone, but with other ingredients to deter abuse.</description>
    <link>http://www.ibtimes.com/articles/20080617/acura-pain-pill-meets-goal-in-late-stage-trial.htm</link> 
  <pubDate>Tue, 17 Jun 2008 10:52:02 EDT</pubDate>
  </item>


  <item>
  <title>King pays Acura $3M for product license</title>
  <description>Acura Pharmaceuticals Inc. said Tuesday that King Pharmaceuticals Inc. has paid the drug maker $3 million to exercise its option to license a third opioid pain medicine using Acura&amp;#39;s Aversion Technology.</description>
    <link>http://www.ibtimes.com/articles/20080527/king-pays-acura-3m-for-product-license.htm</link> 
  <pubDate>Tue, 27 May 2008 09:16:31 EDT</pubDate>
  </item>


</channel>
</rss>